E. Suominen

Who Needs Information and Why

E. Suominen, 1976 .

Efficient infection of tumor endothelial cells by a capsid-modified adenovirus

V. Kähäri, S. Woo, A. Lieber, 2006, Gene Therapy.

Retargeting improves the efficacy of a telomerase-dependent oncolytic adenovirus for head and neck cancer.

M. Savontaus, R. Grénman, E. Suominen, 2009, Oncology reports.

Head and neck cancer cells are efficiently infected by Ad5/35 hybrid virus

M. Savontaus, R. Grénman, E. Suominen, 2006, The journal of gene medicine.